Eagle Asset Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $4.86M | Buy |
+168,795
| New | +$4.86M | 0.02% | 392 |
|
|
2024
Q2 | – | Sell |
-87,064
| Closed | -$1.29M | – | 596 |
|
|
2024
Q1 | $1.29M | Buy |
+87,064
| New | +$1.29M | 0.01% | 488 |
|
|
2022
Q3 | – | Sell |
-701,690
| Closed | -$2.98M | – | 577 |
|
|
2022
Q2 | $2.98M | Buy |
701,690
+226,500
| +48% | +$963K | 0.02% | 413 |
|
|
2022
Q1 | $4.52M | Buy |
475,190
+22,837
| +5% | +$217K | 0.02% | 391 |
|
|
2021
Q4 | $8.75M | Sell |
452,353
-5,793
| -1% | -$112K | 0.04% | 329 |
|
|
2021
Q3 | $15.2M | Sell |
458,146
-381,108
| -45% | -$12.7M | 0.07% | 245 |
|
|
2021
Q2 | $32.6M | Buy |
839,254
+7,707
| +0.9% | +$299K | 0.14% | 192 |
|
|
2021
Q1 | $40.7M | Sell |
831,547
-524,305
| -39% | -$25.7M | 0.18% | 176 |
|
|
2020
Q4 | $70.5M | Sell |
1,355,852
-122,877
| -8% | -$6.39M | 0.4% | 87 |
|
|
2020
Q3 | $38.7M | Buy |
1,478,729
+33,677
| +2% | +$881K | 0.2% | 173 |
|
|
2020
Q2 | $26.8M | Buy |
+1,445,052
| New | +$26.8M | 0.15% | 188 |
|